Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 60

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Pseudomonas aeruginosa and Its Arsenal of Proteases: Weapons to Battle the Host

Galdino, Anna Clara M., Branquinha, Marta H., Santos, André L. S., Viganor, Lívia·2017·Pathophysiological Aspects of Proteases
DOI 10.1007/978-981-10-6141-7_16
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-981-10-6141-7_16

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 83

  1. Tümmler B, Wiehlmann L, Klockgether J et al (2014) Advances in understanding Pseudomonas. F1000 Prime 6:9 · DOI
  2. Jayaseelan S, Ramaswamy D, Dharmaraj S (2014) Pyocyanin: production, applications, challenges and new insights. World J Microbiol Biotechnol 30:1159–1168 · doi:10.1007/s11274-013-1552-5
  3. Vasil ML (1986) Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology. J Pediatr 108:800–805 · doi:10.1016/s0022-3476(86)80748-x
  4. Wiehlmann L, Wagner G, Cramer N et al (2007) Population structure of Pseudomonas aeruginosa. PNAS 104:8101–8106 · DOI · Paper page
  5. Ghodhbane H, Elaidi S, Sabatier JM et al (2015) Bacteriocins active against multi-resistant gram negative bacteria implicated in nosocomial infections. Infect Disord Drug Targets 15:2–12 · doi:10.2174/1871526514666140522113337
  6. Nielsen SL (2015) The incidence and prognosis of patients with bacteremia. Dan Med J 62:B5128
  7. Rosenthal VD, Maki DG, Mehta Y, Leblebicioglu H et al (2014) International nosocomial Infection Control Consortium. International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007–2012. Device-associated module. Am J Infect Control 42:942–956 · DOI · Paper page
  8. Pendleton JN, Gorman SP, Gilmore BF (2013) Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 11:297–308 · DOI · Paper page
  9. Buhl M, Peter S, Willmann M (2013) Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systemic review. Expert Rev Anti-infect Ther 13:1159–1170 · DOI
  10. El Zowalaty ME, Al Thani AA, Webster TJ et al (2015) Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies. Future Microbiol 10:1683–1706 · DOI · Paper page
  11. Bentzmann S, Plésiat P (2011) The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environ Microbiol 13:1655–1665 · DOI · Paper page
  12. Silva LV, Galdino ACM, Nunes APF et al (2014) Virulence attributes in Brazilian clinical isolates of Pseudomonas aeruginosa. Int J Med Microbiol 304:990–1000 · DOI
  13. Balasubramanian D, Schneper L, Kumari H, Mathee K (2013) A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence. Nucleic Acids Res 41:1–20 · DOI · Paper page
  14. Savoia D (2014) New perspectives in the management of Pseudomonas aeruginosa infections. Future Microbiol 9:917–928 · DOI
  15. Kaye KS, Pogue JM (2015) Infections caused by resistant Gram-negative bacteria: epidemiology and management. Pharmacotherapy 35:949–962 · DOI · Paper page
  16. McCarthy K (2015) Pseudomonas aeruginosa: evolution of antimicrobial resistance and implications for therapy. Semin Respir Crit Care Med 36:44–55 · DOI
  17. Sousa AM, Pereira MO (2014) Pseudomonas aeruginosa diversification during infection development in cystic fibrosis lungs—a review. Pathogens 3:680–703 · DOI · Paper page
  18. Oliver A, Mulet X, López-Causapé C, Juan C (2015) The increasing threat of Pseudomonas aeruginosa high-risk clones. Drug Resist Update 22:41–59 · DOI · Paper page
  19. Kung VL, Ozer EA, Hauser AR (2010) The accessory genome of Pseudomonas aeruginosa. Microbiol Mol Biol 74:621–664 · DOI · Paper page
  20. Crousilles A, Maunders E, Bartlett S, Fan C et al (2015) Which microbial factors really are important in Pseudomonas aeruginosa infections? Future Microbiol 10:1825–1836 · DOI
  21. Ballok AE, O’Toole GA (2013) Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl− flux in the lung. J Bacteriol 195:4013–4019 · DOI
  22. Kessler E, Safrin M (2014) Elastinolytic and proteolytic enzymes. In Pseudomonas methods and protocols. Methods Mol Biol 1149:135–169 · DOI
  23. McCarty SM, Cochrane CA, Clegg PD, Percival SL (2012) The role of endogenous and exogenous enzymes in chronic wounds: a focus on the implications of aberrant levels of both host and bacterial proteases in wound healing. Wound Repair Regen 20:125–136 · DOI · Paper page
  24. Schmidtchen A, Wolff H, Hansson C (2001) Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers. Acta Derm Venereol 81:406–409 · DOI
  25. Tingpej P, Smith L, Rose B et al (2007) Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol 45:1697–1704 · DOI
  26. Thibodeau PH, Butterworth MB (2013) Proteases, cystic fibrosis and the epithelial sodium channel (ENaC). Cell Tissue Res 351:309–323 · DOI
  27. Stover CK, Pham XQ, Erwin AL et al (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959–964 · DOI · Paper page
  28. Marquart ME, Dajcs JJ, Caballero AR et al (2005) Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factor. Med Microbiol Immunol 194:39–45 · doi:10.1007/s00430-003-0207-9
  29. Hastie AT, Hingley ST, Kueppers F (1983) Protease production by Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Infect Immun 40:506–513 · doi:10.1128/iai.40.2.506-513.1983
  30. Hoge R, Pelzer A, Rosenau F, Wilhelm S (2010) Weapons of a pathogen: proteases and their role in virulence of Pseudomonas aeruginosa. In: Méndez-Vilas A (ed) Current research, technology and education topics in applied microbiology and microbial biotechnology. Formatex Research Center, Badajoz, pp. 383–395
  31. Hamdaoui A, Wund-Bisseret F, Bieth JG (1987) Fast solubilization of human lung elastin by Pseudomonas aeruginosa elastase. Am Rev Respir Dis 135:860–863 · DOI
  32. Saulnier JM, Curtil FM, Duclos MC, Wallach JM (1989) Elastolytic activity of Pseudomonas aeruginosa elastase. Biochim Biophys Acta 995:285–290 · DOI
  33. Yang J, Zhao HL, Ran YL et al (2015) Mechanistic insights into elastin degradation by pseudolysin, the major virulence factor of the opportunistic pathogen Pseudomonas aeruginosa. Sci Rep 9936 · DOI
  34. Bruce MC, Poncz L, Klinger JD et al (1985) Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis 132:529–535
  35. Erickson DL, Endersby R, Kirkham A et al (2002) Pseudomonas aeruginosa quorum-sensing systems may control virulence factor expression in the lungs of patients with cystic fibrosis. Infect Immun 70:1783–1790 · DOI · Paper page
  36. Kosorok MR, Zeng L, West SE et al (2001) Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 32:277–287 · DOI · Paper page
  37. Voynow JA, Fischer BM, Zheng S (2008) Proteases and cystic fibrosis. Int J Biochem Cell Biol 40:1238–1245 · DOI · Paper page
  38. Van’t Wout EF, van Schadewijk A, van Boxtel R et al (2015) Virulence factors of Pseudomonas aeruginosa induce both the unfolded protein and integrated stress responses in airway epithelial cells. PLoS Pathog 11:e1004946 · DOI
  39. Schultz DR, Miller KD (1974) Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors. Infect Immun 10:128–135 · DOI · Paper page
  40. Hamood A, Griswold G, Colmer J (1996) Characterization of elastase-deficient clinical isolates of Pseudomonas aeruginosa. Infect Immun 64:3154–3160 · DOI
  41. Woods DE, Schaffer MS, Rabin HR et al (1988) Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Bacteriol 170:4309–4314 · DOI · Paper page
  42. Komori Y, Nonogaki T, Nikai T (2001) Hemorrhagic activity and muscle damaging effect of Pseudomonas aeruginosa metalloproteinase (elastase). Toxicon 39:1327–1332 · DOI
  43. Bentzmann S, Polette M, Zahm JM et al (2000) Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase-2. Lab Invest 80:209–219 · DOI
  44. Kida Y, Higashimoto Y, Inoue H et al (2008) A novel secreted protease from Pseudomonas aeruginosa activates NF-kappaB through protease-activated receptors. Cell Microbiol 10:491–504 · DOI
  45. Clark CA, Thomas LK, Azghani AO (2011) Inhibition of protein kinase C attenuates Pseudomonas aeruginosa elastase-induced epithelial barrier disruption. Am J Respir Cell Mol Biol 45:1263–1271 · DOI
  46. Cosgrove S, Chotirmall SH, Greene CM et al (2011) Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway. J Biol Chem 286:692–704 · DOI
  47. Kuang Z, Hao Y, Walling BE et al (2011) Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A. PLoS ONE 6:e27091 · DOI
  48. Nomura K, Obata K, Keira T et al (2014) Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells. Respir Res 18:15–21
  49. Horvat RT, Clabaugh M, Duval-Jobe C, Parmely MJ (1989) Inactivation of human gamma interferon by Pseudomonas aeruginosa proteases: elastase augments the effects of alkaline protease despite the presence of alpha 2-macroglobulin. Infect Immun 57:1668–1674 · DOI
  50. Leidal KG, Munson KL, Johnson MC et al (2003) Metalloproteases from Pseudomonas aeruginosa degrade human RANTES, MCP-1, and ENA-78. J Interferon Cytokine Res 23:307–318 · DOI
  51. Mariencheck WI, Alcorn JF, Palmer SM (2003) Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. Am J Respir Cell Mol Biol 28:528–537 · DOI
  52. Meyer KC, Sharma R, Brown M et al (2000) Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis. Chest 118:164–174 · DOI
  53. McCormick CC, Hobden JA, Balzli CL et al (2007) Surfactant protein D in Pseudomonas aeruginosa keratitis. Ocular Immun Inflam 15:371–379 · doi:10.1080/09273940701486423
  54. Bainbridge T, Fick RB (1989) Functional importance of cystic fibrosis immunoglobulin G fragments generated by Pseudomonas aeruginosa elastase. J Lab Clin Med 114:728–733
  55. Heck LW, Alarcon PG, Kulhavy RM et al (1990) Degradation of IgA proteins by Pseudomonas aeruginosa elastase. J Immunol 144:2253–2257 · DOI
  56. Lomholt JA, Kilian M (2008) Degradation of uniquely glycosylated secretory immunoglobulin A in tears from patients with Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 49:1944–4939 · doi:10.1167/iovs.07-1198
  57. Tielen P, Rosenau F, Wilhelm S et al (2010) Extracellular enzymes affect biofilm formation of mucoid Pseudomonas aeruginosa. Microbiology 156:2239–2252 · DOI
  58. Yu H, He X, Xie W et al (2014) Elastase LasB of Pseudomonas aeruginosa promotes biofilm formation partly through rhamnolipid-mediated regulation. Can J Microbiol 60:227–235 · DOI
  59. Schad PA, Iglewski BH (1988) Nucleotide sequence and expression in Escherichia coli of the Pseudomonas aeruginosa lasA gene. J Bacteriol 170:2784–2789 · doi:10.1128/jb.170.6.2784-2789.1988
  60. Kessler E, Safrin M, Gustin JK et al (1998) Elastase and the LasA protease of Pseudomonas aeruginosa are secreted with their propeptides. J Biol Chem 273:30225–30231 · DOI
  61. Engel LS, Hill JM, Caballero AR (1998) Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa. J Biol Chem 273:16792–16797 · doi:10.1074/jbc.273.27.16792
  62. Wilderman PJ, Vasil AI, Johnson Z (2001) Characterization of an endoprotease (prpl) encoded by a pvds-regulated gene in Pseudomonas aeruginosa. Infect Immun 69:5385–5394 · DOI · Paper page
  63. Barequet IS, Bourla N, Pessach YN et al (2012) Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis. Graefes Arch Clin Exp Ophthalmol 250:223–229 · doi:10.1007/s00417-011-1822-6
  64. Kessler E, Safrin M, Abrams WR, Rosenbloom J, Ohman DE (1997) Inhibitors and specificity of Pseudomonas aeruginosa LasA. J Biol Chem 272:9884–9889 · DOI
  65. Kessler E, Safrin M, Blumberg S, Ohman DE (2004) A continuous spectrophotometric assay for Pseudomonas aeruginosa LasA prote- ase (staphylolysin) using a two-stage enzymatic reaction. Anal Biochem 328:225–232 · DOI
  66. Vessillier S, Delolme F, Bernillon J, Saulnier J, Wallach J (2001) Hydrolysis of glycine-containing elastin pentapeptides by LasA, a metalloelastase from Pseudomonas aeruginosa. Eur J Biochem 268:1049–1057 · DOI
  67. Peters JE, Galloway DR (1990) Purification and characterization of an active fragment of the LasA protein from Pseudomonas aeruginosa: enhancement of elastase activity. J Bacteriol 172:2236–2240 · doi:10.1128/jb.172.5.2236-2240.1990
  68. Peters JE, Park SJ, Darzins A et al (1992) Further studies on Pseudomonas aeruginosa LasA: analysis of specificity. Mol Microbiol 6:1155–1162 · doi:10.1111/j.1365-2958.1992.tb01554.x
  69. Laarman AJ, Bardoel BW, Ruyken M et al (2012) Pseudomonas aeruginosa alkaline protease blocks complement activation via the classical and lectin pathways. J Immunol 188:386–393 · DOI · Paper page
  70. Kharazmi A, Hoiby N, Doring G, Valerius NH (1984) Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence. Infect Immun 44:587–591 · DOI
  71. Hong YQ, Ghebrehiwet B (1992) Effect of Pseudomonas aeruginosa elastase and alkaline protease on serum complement and isolated components C1q and C3. Clin Immunol Immunopathol 62:133–138 · DOI · Paper page
  72. Bardoel BW, van Kessel KP, van Strijp JA, Milder FJ (2012) Inhibition of Pseudomonas aeruginosa virulence: characterization of the AprA-AprI interface and species selectivity. J Mol Biol 415:573–583 · DOI
  73. Kim SJ, Park RY, Kang SM (2006) Pseudomonas aeruginosa alkaline protease can facilitate siderophore-mediated iron-uptake via the proteolytic cleavage of transferrins. Biol Pharm Bull 29:2295–22300 · DOI
  74. Gupta SK, Masinick SA, Hobden JA et al (1996) Bacterial proteases and adherence of Pseudomonas aeruginosa to mouse cornea. Exp Eye Res 62:641–650 · DOI
  75. Malloy JL1, Veldhuizen RA, Thibodeaux BA et al (2005) Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. Am J Physiol Lung Cell Mol Physiol 288:409–418 · DOI
  76. Traidej M, Caballero AR, Marquart ME et al (2003) Molecular analysis of Pseudomonas aeruginosa protease IV expressed in Pseudomonas putida. Invest Ophthalmol Vis Sci 44:190–196 · doi:10.1167/iovs.02-0458
  77. Matsumoto K (2004) Role of bacterial proteases in pseudomonal and serratial keratitis. Biol Chem 385:1007–1016 · DOI
  78. Engel LS, Hobden JA, Moreau JM et al (1997) Pseudomonas deficient in protease IV has significantly reduced corneal virulence. Invest Ophthalmol Vis Sci 38:1535–1542
  79. Tang A, Marquart ME, Fratkin JD et al (2009) Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions. Invest Ophthalmol Vis Sci 50:3794–3801 · DOI
  80. Tang A, Caballero AR, Marquart ME, O’callaghan RJ (2013) Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor. Invest Ophthalmol Vis Sci 54:2821–2828 · DOI
  81. Kida Y, Shimizu T, Kuwano K (2011) Cooperation between LepA and PlcH contributes to the in vivo virulence and growth of Pseudomonas aeruginosa in mice. Infect Immun 79:211–219 · DOI
  82. Mochizuki Y, Suzuki T, Oka N, Zhang Y et al (2014) Pseudomonas aeruginosa MucD protease mediates keratitis by inhibiting neutrophil recruitment and promoting bacterial survival. Invest Ophthalmol Vis Sci 55:240–246 · doi:10.1167/iovs.13-13151
  83. Okuda J, Hayashi N, Tanabe S et al (2011) Degradation of interleukin 8 by the serine protease MucD of Pseudomonas aeruginosa. Infect Chemother 17:782–792 · DOI

Cited by

See all 60

Metadata

Authors
Galdino, A. C. M., Branquinha, M. H., Santos, A. L. S., & Viganor, L.
Venue
Pathophysiological Aspects of Proteases
Publisher
Springer Singapore
Published
2017
Pages
381-397
DOI
10.1007/978-981-10-6141-7_16
Cited by
60
References
4
Language
en
Licence
www.springer.com/tdm (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pseudomonas aeruginosa and Its Arsenal of Proteases: Weapons to Battle the Host. https://app.cochat.ai/papers/10.1007/978-981-10-6141-7_16
The paper
Galdino, A. C. M., Branquinha, M. H., Santos, A. L. S., & Viganor, L. (2017). Pseudomonas aeruginosa and Its Arsenal of Proteases: Weapons to Battle the Host. Pathophysiological Aspects of Proteases. https://doi.org/10.1007/978-981-10-6141-7_16

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.